Exercise therapy for chronic symptomatic peripheral artery disease
A clinical consensus document of the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases in collaboration with the European Society of Vascular Medicine and the European Society for Vascular Surgery
Abstract
Summary: All guidelines worldwide strongly recommend exercise as a pillar in the management of patients affected by lower extremity peripheral artery disease (PAD). Exercise therapy in this setting presents different modalities, and a structured programme provides optimal results. This clinical consensus paper is intended to promote and assist the set up of comprehensive exercise programmes and best advice for patients with symptomatic chronic PAD. Different exercise training protocols specific for patients with PAD are presented. Data on patient assessment and outcome measures are described based on the current best evidence. The document ends by highlighting supervised exercise programme access disparities across Europe and the evidence gaps requiring further research.
References
1 2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J. 2021;42:17–96.
2 Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health. 2019;7:e1020–30.
3 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39:763–816.
4 ESVM guideline on peripheral arterial disease. Vasa. 2019;48:1–79.
5 . Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia. Circ Res. 2015;116:1540–50.
6 The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med. 2002;136:873–83.
7 Decline in functional performance predicts later increased mobility loss and mortality in peripheral arterial disease. J Am Coll Cardiol. 2011;57:962–70.
8 Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation. 1996;94:3026–49.
9 . The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Organ. 1962;27:645–58.
10 . Exertional leg symptoms other than intermittent claudication are common in peripheral arterial disease. Arch Intern Med. 1999;159:387–92.
11 . Pathogenesis of the limb manifestations and exercise limitations in peripheral artery disease. Circ Res. 2015;116:1527–39.
12 . Pain management in patients with vascular disease. Br J Anaesth. 2016;117:ii95–ii106.
13 . Impaired somatosensation in patients with isolated proximal-without-distal exercise-related lower-limb ischemia. Clin J Pain. 2012;28:404–9.
14 The effect of post-exercise ankle-brachial index on lower extremity revascularization. JACC Cardiovasc Interv. 2015;8:1238–44.
15 Walking exercise therapy effects on lower extremity skeletal muscle in peripheral artery disease. Circ Res. 2021;128:1851–67.
16 . Usefulness of postexercise ankle-brachial index to predict all-cause mortality. Am J Cardiol. 2011;107:778–82.
17 The assessment of endothelial function: from research into clinical practice. Circulation. 2012;126:753–67.
18 Effect of exercise on upper and lower extremity endothelial function in patients with coronary artery disease. Am J Cardiol. 2002;90:124–7.
19 . Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. Am J Physiol. 1996;270:H1435–40.
20 . Does endothelial dysfunction contribute to the clinical status of patients with peripheral arterial disease? Can J Cardiol. 2010;26:45A–50A.
21 Relationship between leg muscle capillary density and peak hyperemic blood flow with endurance capacity in peripheral artery disease. J Appl Physiol (1985). 2011;111:81–6.
22 . Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death). Am J Cardiol. 2005;96:1374–8.
23 . C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation. 2005;112:976–83.
24 Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study. Ann Intern Med. 2008;148:85–93.
25 Leg symptom categories and rates of mobility decline in peripheral arterial disease. J Am Geriatr Soc. 2010;58:1256–62.
26 . Altered gait profile in subjects with peripheral arterial disease. Vasc Med. 2001;6:31–4.
27 Prolonged stance phase during walking in intermittent claudication. J Vasc Surg. 2017;66:515–22.
28 Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA. 2004;292:453–61.
29 . The effect of claudication pain on temporal and spatial gait measures during self-paced ambulation. Vasc Med. 2010;15:21–6.
30 Abnormal joint powers before and after the onset of claudication symptoms. J Vasc Surg. 2010;52:340–7.
31 . Joint torques and powers are reduced during ambulation for both limbs in patients with unilateral claudication. J Vasc Surg. 2010;51:80–8.
32 Muscle strength and control characteristics are altered by peripheral artery disease. J Vasc Surg. 2017;66:178–86.
33 . Impaired balance and higher prevalence of falls in subjects with intermittent claudication. J Gerontol A Biol Sci Med Sci. 2001;56:M454–8.
34 Balance impairment, physical ability, and its link with disease severity in patients with intermittent claudication. Ann Vasc Surg. 2013;27:68–74.
35 Using wearable monitors to assess daily walking limitations induced by ischemic pain in peripheral artery disease. Scand J Med Sci Sports. 2019;29:1813–26.
36 Associations of borderline and low normal ankle-brachial index values with functional decline at 5-year follow-up: the WALCS (Walking and Leg Circulation Study). J Am Coll Cardiol. 2009;53:1056–62.
37 Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation. 2012;126:2890–909.
38 Implementation of supervised exercise therapy for patients with symptomatic peripheral artery disease: a science advisory from the American Heart Association. Circulation. 2019;140:e700–10.
39 . Progressive vs single-stage treadmill tests for evaluation of claudication. Med Sci Sports Exerc. 1991;23:402–8.
40 . Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists. Circulation. 1995;92:614–21.
41 . The treadmill is a better functional test than the 6-minute walk test in therapeutic trials of patients with peripheral artery disease. Circulation. 2014;130:69–78.
42 . Reliability of treadmill testing in peripheral arterial disease: a meta-regression analysis. J Vasc Surg. 2009;50:322–9.
43 . ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111–7.
44 . Learning from the learning effect in the six-minute-walk test. Am J Respir Crit Care Med. 2012;185:684.
45 . Feasibility and validity of self-reported walking capacity in patients with intermittent claudication. J Vasc Surg. 2013;57:1227–34.
46 . Six-minute walk is a better outcome measure than treadmill walking tests in therapeutic trials of patients with peripheral artery disease. Circulation. 2014;130:61–8.
47 . Corridor-based functional performance measures correlate better with physical activity during daily life than treadmill measures in persons with peripheral arterial disease. J Vasc Surg. 2008;48:1231–7.
48 Baseline functional performance predicts the rate of mobility loss in persons with peripheral arterial disease. J Am Coll Cardiol. 2007;50:974–82.
49 . Test-retest reliability, agreement, and minimal detectable change in the 6-minute walk test in patients with intermittent claudication. J Vasc Surg. 2020;71:197–203.
50 Meaningful change in 6-minute walk in people with peripheral artery disease. J Vasc Surg. 2021;73:267–76.
51 . Minimal clinically important differences in treadmill, 6-minute walk, and patient-based outcomes following supervised and home-based exercise in peripheral artery disease. Vasc Med. 2018;23:349–57.
52 . Clinical interest of ambulatory assessment of physical activity and walking capacity in peripheral artery disease. Scand J Med Sci Sports. 2016;26:716–30.
53 The inter- and intra-unit variability of a low-cost GPS data logger/receiver to study human outdoor walking in view of health and clinical studies. PLoS One. 2012;7:e31338.
54 Comparison of activity monitors accuracy in assessing intermittent outdoor walking. Med Sci Sports Exerc. 2021;53:1303–14.
55 . Validity of activity trackers, smartphones, and phone applications to measure steps in various walking conditions. Scand J Med Sci Sports. 2018;28:1818–27.
56 . Measurement of walking distance and speed in patients with peripheral arterial disease: a novel method using a global positioning system. Circulation. 2008;117:897–904.
57 Associations between lower extremity ischemia, upper and lower extremity strength, and functional impairment with peripheral arterial disease. J Am Geriatr Soc. 2008;56:724–9.
58 Sarcopenia and peripheral arterial disease: a systematic review. J Cachexia Sarcopenia Muscle. 2020;11:866–86.
59 . Test-retest reliability of isokinetic strength and endurance tests in patients with intermittent claudication. Vasc Med. 2010;15:275–8.
60 A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49:M85–94.
61 . Sit to stand muscle power is related to functional performance at baseline and after supervised exercise training in patients with lower extremity peripheral artery disease. Eur J Vasc Endovasc Surg. 2023;65:521–7.
62 A Delphi consensus on patient reported outcomes for registries and trials including patients with intermittent claudication: recommendations and reporting standard. Eur J Vasc Endovasc Surg. 2022;64:526–33.
63 . Assessing health-related quality of life among patients with peripheral artery disease: a review of the literature and focus on patient-reported outcome measures. Vasc Med. 2021;26:317–25.
64 Optimal exercise programs for patients with peripheral artery disease: a scientific statement from the American Heart Association. Circulation. 2019;139:e10–33.
65 The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) program. Vasc Med. 2008;13:15–24.
66 . Functional status and health-related quality of life in patients with peripheral artery disease: a cross-sectional study. Int J Environ Res Public Health. 2021;18:10941.
67 . Effects of physical activity on life expectancy with cardiovascular disease. Arch Intern Med. 2005;165:2355–60.
68 . The relationship between physical activity, self-perceived health, and cognitive function in older adults. Brain Sci. 2021;11:492.
69 . 5 Conservative treatment for PAD—risk factor management. Vasa. 2019;48:1–12.
70 Exercise training for intermittent claudication: a narrative review and summary of guidelines for practitioners. BMJ Open Sport Exercise Med. 2020;6:e000897.
71 . Safety of supervised exercise therapy in patients with intermittent claudication. J Vasc Surg. 2015;61:512–8.
72 . Connecting the past to the present: a historical review of exercise training for peripheral artery disease. Vasc Med. 2022;27:174–85.
73 Winners do what they fear: exercise and peripheral arterial disease-an umbrella review. Eur J Prev Cardiol. 2023:zwad261.
74 . Exercise for intermittent claudication. Cochrane Database Syst Rev. 2017;12:CD000990.
75 Supervised walking therapy in patients with intermittent claudication. J Vasc Surg. 2012;56:1132–42.
76 . Gait changes after supervised exercise training in patients with symptomatic lower extremity peripheral artery disease. Vasc Med. 2021;26:259–66.
77 . Supervised exercise training improves 6 min walking distance and modifies gait pattern during pain-free walking condition in patients with symptomatic lower extremity peripheral artery disease. Sensors (Basel). 2021;21:7989.
78 . Intensity-dependent effects of exercise therapy on walking performance and aerobic fitness in symptomatic patients with lower-extremity peripheral artery disease: a systematic review and meta-analysis. Vasc Med. 2022;27:158–70.
79 . Time-course evolution of functional performance during a 3-month supervised exercise training program in patients with symptomatic peripheral artery disease. Vasc Med. 2023;28:404–11.
80 . Exercise training for health-related quality of life in peripheral artery disease: a systematic review and meta-analysis. Vasc Med. 2015;20:30–40.
81 . Exercise training for management of peripheral arterial disease: a systematic review and meta-analysis. Sports Med. 2015;45:231–44.
82 Supervised walking exercise therapy improves gait biomechanics in patients with peripheral artery disease. J Vasc Surg. 2019;71:575–83.
83 Cardiovascular rehabilitation increases walking distance in patients with intermittent claudication. Results of the CIPIC Rehab Study: a randomised controlled trial. Eur J Vasc Endovasc Surg. 2021;62:768–76.
84 . Cilostazol for intermittent claudication. Cochrane Database Syst Rev. 2021;6:CD003748.
85 . Effect of bosentan on claudication distance and endothelium-dependent vasodilation in Hispanic patients with peripheral arterial disease. Am J Cardiol. 2016;117:295–301.
86 Effects of sildenafil on maximum walking time in patients with arterial claudication: the ARTERIOFIL study. Vascul Pharmacol. 2019;118–119:106563.
87 Current therapies and investigational drugs for peripheral arterial disease. Hypertens Res. 2016;39:183–91.
88 . Pentoxifylline for intermittent claudication. Cochrane Database Syst Rev. 2020;10:CD005262.
89 . Modes of exercise training for intermittent claudication. Cochrane Database Syst Rev. 2020;8:CD009638.
90 . High-intensity progressive resistance training improves flat-ground walking in older adults with symptomatic peripheral arterial disease. J Am Geriatr Soc. 2013;61:1964–70.
91 Strength training increases walking tolerance in intermittent claudication patients: randomized trial. J Vasc Surg. 2010;51:89–95.
92 . Short-term effects of cycle and treadmill training on exercise tolerance in peripheral arterial disease. J Vasc Surg. 2006;44:119–27.
93 Polestriding exercise and vitamin E for management of peripheral vascular disease. Med Sci Sports Exerc. 2003;35:384–93.
94 Cardiovascular training effect associated with polestriding exercise in patients with peripheral arterial disease. J Cardiovasc Nurs. 2005;20:177–85.
95 . Multimodal supervised exercise significantly improves walking performances without changing hemodynamic parameters in patients with symptomatic lower extremity peripheral artery disease. Vasc Endovascular Surg. 2020;54:605–11.
96 . Improvement in 6-minute walking distance after supervised exercise training is related to changes in quality of life in patients with lower extremity peripheral artery disease. J Clin Med. 2021;10:3330.
97 . Walking performances and muscle oxygen desaturation are increased after supervised exercise training in Takayasu arteritis: a case report and a review of the literature. Eur Heart J Case Rep. 2018;2:yty123.
98 . Multimodal supervised exercise training is effective in improving long term walking performance in patients with symptomatic lower extremity peripheral artery disease. J Clin Med. 2021;10:2057.
99 . Limb-specific and cross-transfer effects of arm-crank exercise training in patients with symptomatic peripheral arterial disease. Clin Sci (Lond). 2009;117:405–13.
100 . Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication. Vasc Med. 2009;14:203–13.
101 . A systematic review of randomized controlled trials: walking versus alternative exercise prescription as treatment for intermittent claudication. Atherosclerosis. 2011;218:1–12.
102 Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA. 2009;301:165–74.
103 . Optimising exercise training in peripheral arterial disease. Sports Med. 2004;34:983–1003.
104 . Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA. 1995;274:975–80.
105 . Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14:377–81.
106 . Peripheral arterial disease—diagnosis and management in general practice. Aust Fam Physician. 2013;42:397–400.
107 Effects of walking exercise at a pace with versus without ischemic leg symptoms on functional performance measures in people with lower extremity peripheral artery disease: the LITE randomized clinical trial. J Am Heart Assoc. 2022;11:e025063.
108 Effect of low-intensity vs high-intensity home-based walking exercise on walk distance in patients with peripheral artery disease: the LITE randomized clinical trial. JAMA. 2021;325:1266–76.
109 Comparison of two treadmill training programs on walking ability and endothelial function in intermittent claudication. Int J Cardiol. 2013;168:838–42.
110 Moderate-pain versus pain-free exercise, walking capacity, and cardiovascular health in patients with peripheral artery disease. J Vasc Surg. 2019;70:148–56.
111 Effect of high-pain versus low-pain structured exercise on walking ability in people with intermittent claudication: meta-analysis. Br J Surg. 2022;109:686–94.
112 A systematic review of exercise prescription in patients with intermittent claudication: does pain matter? Ann Vasc Surg. 2021;77:315–23.
113 Effects of exercise prescribed at different levels of claudication pain on walking performance in patients with intermittent claudication: a protocol for a randomised controlled trial. Ther Adv Cardiovasc Dis. 2022;16:17539447221108817.
114 . Commentary to Seed, et al. What is the correct level of claudication pain to prescribe? Universal inconsistency within guidelines, a painful issue. Vascular. 2023. https://doi.org/10.1177/17085381231160931. [Epub 5 April 2023].
115 American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc. 2011;43:1334–59.
116 Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: why and how: a position statement from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2022;29:230–45.
117 . Accuracy of seven equations for predicting 1-RM performance of apparently healthy, sedentary older adults. Meas Phys Educ Exerc Sci. 2002;6:67–94.
118 . Resistance training as a treatment for older persons with peripheral artery disease: a systematic review and meta-analysis. Br J Sports Med. 2019;54:452–61.
119 An updated systematic review and meta-analysis of home-based exercise programs for individuals with intermittent claudication. J Vasc Surg. 2021;74:2076–85.
120 . The effect of supervised exercise, home based exercise and endovascular revascularisation on physical activity in patients with intermittent claudication: a network meta-analysis. Eur J Vasc Endovasc Surg. 2019;58:383–92.
121 A group-mediated, home-based physical activity intervention for patients with peripheral artery disease: effects on social and psychological function. J Transl Med. 2014;12:29.
122 . Long-term effects of structured home-based exercise program on functional capacity and quality of life in patients with intermittent claudication. Arch Phys Med Rehabil. 2011;92:1066–73.
123 Home-based walking exercise in peripheral artery disease: 12-month follow-up of the GOALS randomized trial. J Am Heart Assoc. 2014;3:e000711.
124 . Safety of home-based exercise for people with intermittent claudication: a systematic review. Vasc Med. 2022;27:186–92.
125 Changes in exercise capacity and risk of all-cause mortality in patients with peripheral artery disease: a 10-year retrospective cohort study. Intern Emerg Med. 2020;15:289–98.
126 . Supervised exercise therapy versus home-based exercise therapy versus walking advice for intermittent claudication. Cochrane Database Syst Rev. 2018;4:CD005263.
127 . Systematic review of home-based exercise programmes for individuals with intermittent claudication. Eur J Vasc Endovasc Surg. 2013;46:690–706.
128 National assessment of availability, awareness, and utilization of supervised exercise therapy for peripheral artery disease patients with intermittent claudication. J Vasc Surg. 2020;71:1702–7.
129 . Few UK vascular centres offer a fully NICE-compliant supervised exercise programme: a national audit. Ann R Coll Surg Engl. 2022;104:130–7.
130 . Provision of exercise services in patients with peripheral artery disease in the United Kingdom. Vascular. 2022;30:874–81.
131 . Availability of supervised exercise programs and the role of structured home-based exercise in peripheral arterial disease. Eur J Vasc Endovasc Surg. 2012;44:569–75.; discussion 76.
132 . Diabetic women are poor responders to exercise rehabilitation in the treatment of claudication. J Vasc Surg. 2014;59:1036–43.
133 Gender differences in outcomes following a pain-free, home-based exercise program for claudication. J Womens Health (Larchmt). 2019;28:1313–21.
134 . Sex-specific predictors of improved walking with step-monitored, home-based exercise in peripheral artery disease. Vasc Med. 2015;20:424–31.
135 Effects of a home-based walking intervention on mobility and quality of life in people with diabetes and peripheral arterial disease: a randomized controlled trial. Diabetes Care. 2011;34:2174–9.
136 Structured home-based exercise versus invasive treatment: a mission impossible? A pilot randomized study in elderly patients with intermittent claudication. Angiology. 2016;67:772–80.
137 . Home-based exercise: a therapeutic option for peripheral artery disease. Circulation. 2016;134:1127–9.
138 Wearable activity monitors in home based exercise therapy for patients with intermittent claudication: a systematic review. Eur J Vasc Endovasc Surg. 2021;61:676–87.
139 . Effectiveness of mobile health-based exercise interventions for patients with peripheral artery disease: systematic review and meta-analysis. JMIR Mhealth Uhealth. 2021;9:e24080.
140 . Integrative biology of exercise. Cell. 2014;159:738–49.
141 . Exercise-induced capillary growth in human skeletal muscle and the dynamics of VEGF. Microcirculation. 2014;21:301–14.
142 . Invited review: activity-induced angiogenesis. Pflugers Arch. 2009;457:963–77.
143 . The role of exercise and PGC1alpha in inflammation and chronic disease. Nature. 2008;454:463–9.
144 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;69:1465–508.
145 Management of chronic peripheral artery disease patients with indication for endovascular revascularization. Vasa. 2022;51:121–37.
146 Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:1425–43.
147 Editor’s Choice – Randomised clinical trial of supervised exercise therapy vs. endovascular revascularisation for intermittent claudication caused by iliac artery obstruction: the SUPER study. Eur J Vasc Endovasc Surg. 2022;63:421–9.
148 Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the Claudication: Exercise versus Endoluminal Revascularization (CLEVER) study. Circulationz. 2012;125:130–9.
149 Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. J Am Coll Cardiol. 2015;65:999–1009.
150 Influence of peripheral transluminal angioplasty alongside exercise training on oxidative stress and inflammation in patients with peripheral arterial disease. J Clin Med. 2021;10:5851.
151 Comparative efficacy of endovascular revascularization versus supervised exercise training in patients with intermittent claudication: meta-analysis of randomized controlled trials. JACC Cardiovasc Interv. 2017;10:712–24.
152 . Endovascular revascularisation versus conservative management for intermittent claudication. Cochrane Database Syst Rev. 2018;3:CD010512.
153 . Benefits of a supervised exercise program after lower limb bypass surgery. Vasc Endovascular Surg. 2007;41:27–32.
154 Effectiveness of continuous unsupervised exercise therapy after above-knee femoropopliteal bypass. Vascular. 2021;29:387–95.
155 . Combined lower limb revascularisation and supervised exercise training for patients with peripheral arterial disease: a systematic review of randomised controlled trials. Sports Med 2017;47:987–1002.
156 Health-related quality of life predicts long-term survival in patients with peripheral artery disease. Vasc Med. 2010;15:163–9.
157 . Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial. Circulation. 2011;123:491–8.
158 . Value of a supervised exercise program for the therapy of arterial claudication. J Vasc Surg. 1997;25:312–8.
159 The effects of exercise training on walking function and perception of health status in elderly patients with peripheral arterial occlusive disease. J Intern Med. 2002;252:448–55.
160 . Exercise Therapy in Peripheral Arterial Disease Study G. Multicenter randomized clinical trial of supervised exercise therapy with or without feedback versus walking advice for intermittent claudication. J Vasc Surg. 2010;52:348–55.
161 . Exercise-based interventions and health-related quality of life in intermittent claudication: a 20-year (1989–2008) review. Eur J Cardiovasc Prev Rehabil. 2010;17:140–54.
162 . One-year effect of a supervised exercise programme on functional capacity and quality of life in peripheral arterial disease. Disabil Rehabil. 2013;35:397–404.
163 . Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomised controlled trial. Eur J Vasc Endovasc Surg. 2005;30:164–75.
164 Effects of home versus supervised exercise for patients with intermittent claudication. J Cardiopulm Rehabil. 2001;21:152–7.
165 . Predictors of health-related quality of life in patients with symptomatic peripheral artery disease. J Vasc Surg. 2018;68:1126–34.
166 Physical activity, cognition, and brain outcomes: a review of the 2018 physical activity guidelines. Med Sci Sports Exerc. 2019;51:1242–51.
167 . Physical exercise and cognitive performance in the elderly: current perspectives. Clin Interv Aging. 2014;9:51–62.
168 . The influence of exercise on cognitive abilities. Compr Physiol. 2013;3:403–28.
169 Editor’s Choice – The effect of supervision on walking distance in patients with intermittent claudication: a meta-analysis. Eur J Vasc Endovasc Surg. 2014;48:169–84.
170 . The effect of structured patient education on physical activity in patients with peripheral arterial disease and intermittent claudication: a systematic review. Eur J Vasc Endovasc Surg. 2017;54:58–68.
171 Effect of a home-based, walking exercise behavior change intervention vs usual care on walking in adults with peripheral artery disease: the MOSAIC randomized clinical trial. JAMA. 2022;327:1344–55.
172 Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial. JAMA. 2013;310:57–65.
173 Effect of a home-based exercise intervention of wearable technology and telephone coaching on walking performance in peripheral artery disease: the HONOR randomized clinical trial. JAMA. 2018;319:1665–76.
174 Prevalence of peripheral arterial disease, abdominal aortic aneurysm, and risk factors in the Hamburg City Health Study: a cross-sectional analysis. Eur J Vasc Endovasc Surg. 2023;65:590–8.
175 Sex differences in peripheral artery disease. Circ Res. 2022;130:496–511.
176 Editor’s Choice – International variations and sex disparities in the treatment of peripheral arterial occlusive disease: a report from VASCUNET and the International Consortium of Vascular Registries. Eur J Vasc Endovasc Surg. 2020;60:873–80.
177 Women specific characteristics and 1-year outcome among patients hospitalized for peripheral artery disease: a monocentric cohort analysis in a tertiary center. Front Cardiovasc Med. 2022;9:824466.
178 A health insurance claims analysis on the effect of female sex on long-term outcomes after peripheral endovascular interventions for symptomatic peripheral arterial occlusive disease. J Vasc Surg. 2021;74:780–7.
179 A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association. Circulation. 2012;125:1449–72.
180 Sex disparities in long term outcomes after open surgery for chronic limb threatening ischaemia: a propensity score matched analysis of health insurance claims. Eur J Vasc Endovasc Surg. 2021;61:423–9.
181 Leg strength predicts mortality in men but not in women with peripheral arterial disease. J Vasc Surg. 2010;52:624–31.
182 Women with peripheral arterial disease experience faster functional decline than men with peripheral arterial disease. J Am Coll Cardiol. 2011;57:707–14.
183 . Gender differences following supervised exercise therapy in patients with intermittent claudication. J Vasc Surg. 2015;62:681–8.
184 Abnormal oxygen uptake kinetic responses in women with type II diabetes mellitus. J Appl Physiol (1985). 1998;85:310–7.
185 . Sex-based differences in supervised exercise therapy outcomes for symptomatic peripheral artery disease. Vasc Med. 2023;28:147–9.
186 Barriers to participation in supervised exercise therapy reported by people with peripheral artery disease. J Vasc Surg. 2023;77:506–14.
187 Exercise therapy referral and participation in patients with peripheral artery disease: insights from the PORTRAIT registry. Vasc Med. 2021;26:654–6.
188 . Access to supervised exercise services for peripheral vascular disease patients. Bull R Coll Surgeons Engl. 2017;99:207–11.
189 . A systematic review of the uptake and adherence rates to supervised exercise programs in patients with intermittent claudication. Ann Vasc Surg. 2016;34:280–9.
190 A prospective survey study on the education and awareness about walking exercise amongst inpatients with symptomatic peripheral arterial disease in Germany. Vasa. 2023;52:218–23.
191 How German vascular surgeons and angiologists judge walking exercise for patients with PAD. Vasa. 2023;52:224–9.
192 Adherence to guideline-recommended therapy-including supervised exercise therapy referral-across peripheral artery disease specialty clinics: insights from the International PORTRAIT Registry. J Am Heart Assoc. 2020;9:e012541.
193 Supervised exercise training in patients with lower extremity peripheral artery disease. Vasa. 2022;51:267–74.
194 . Hydration may reverse most symptoms of lower extremity intermittent claudication or rest pain. J Vasc Surg. 2020;72:1459–63.
195 . Physical training and antiplatelet treatment in stage II peripheral arterial occlusive disease: alone or combined? Angiology. 1991;42:513–21.
196 . The effect of supervised exercise and cilostazol on coagulation and fibrinolysis in intermittent claudication: a randomized controlled trial. J Vasc Surg. 2007;45:65–70.; discussion 70.